Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

302 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Interleukin 2 with anti-GD2 antibody ch14.18/CHO (dinutuximab beta) in patients with high-risk neuroblastoma (HR-NBL1/SIOPEN): a multicentre, randomised, phase 3 trial.
Ladenstein R, Pötschger U, Valteau-Couanet D, Luksch R, Castel V, Yaniv I, Laureys G, Brock P, Michon JM, Owens C, Trahair T, Chan GCF, Ruud E, Schroeder H, Beck Popovic M, Schreier G, Loibner H, Ambros P, Holmes K, Castellani MR, Gaze MN, Garaventa A, Pearson ADJ, Lode HN. Ladenstein R, et al. Among authors: garaventa a. Lancet Oncol. 2018 Dec;19(12):1617-1629. doi: 10.1016/S1470-2045(18)30578-3. Epub 2018 Nov 12. Lancet Oncol. 2018. PMID: 30442501 Clinical Trial.
Standard-dose and high-dose peptichemio and cisplatin in children with disseminated poor-risk neuroblastoma: two studies by the Italian Cooperative Group for Neuroblastoma.
De Bernardi B, Carli M, Casale F, Corciulo P, Cordero di Montezemolo L, De Laurentis C, Bagnulo S, Brisigotti M, Marchese N, Garaventa A, et al. De Bernardi B, et al. Among authors: garaventa a. J Clin Oncol. 1992 Dec;10(12):1870-8. doi: 10.1200/JCO.1992.10.12.1870. J Clin Oncol. 1992. PMID: 1453202
The role of BMT for neuroblastoma relapse patients. A report of the EBMT-STR.
Ladenstein R, Chauvin F, Garaventa A, Bernard JL, Zucker JM, Lutz P, Bordigoni P, Plouvier E, Cahn JY, Frappaz D, et al. Ladenstein R, et al. Among authors: garaventa a. Bone Marrow Transplant. 1991;7 Suppl 2:90. Bone Marrow Transplant. 1991. PMID: 1878738 Clinical Trial. No abstract available.
High dose peptichemio in pretreated neuroblastoma.
Garaventa A, De Bernardi B, Cordero Di Montezemolo L, Pastore G, De Laurentis C, Nardi E, Casale F, Mancini A, Loiacono G. Garaventa A, et al. Anticancer Res. 1989 Jul-Aug;9(4):1157-60. Anticancer Res. 1989. PMID: 2817797
Impact of megatherapy on survival after relapse from stage 4 neuroblastoma in patients over 1 year of age at diagnosis: a report from the European Group for Bone Marrow Transplantation.
Ladenstein R, Lasset C, Hartmann O, Frappaz D, Garaventa A, Klingebiel T, Zucker JM, Coze C, Burdach S, Gadner H, et al. Ladenstein R, et al. Among authors: garaventa a. J Clin Oncol. 1993 Dec;11(12):2330-41. doi: 10.1200/JCO.1993.11.12.2330. J Clin Oncol. 1993. PMID: 8246022
Localized but unresectable neuroblastoma: treatment and outcome of 145 cases. Italian Cooperative Group for Neuroblastoma.
Garaventa A, De Bernardi B, Pianca C, Donfrancesco A, Cordero di Montezemolo L, Di Tullio MT, Bagnulo S, Mancini A, Carli M, Pession A, Arrighini A, Di Cataldo A, Tamaro P, Iasonni V, Taccone A, Rogers D, Boni L; Italian Cooperative Group dor Neuroblastoma. Garaventa A, et al. J Clin Oncol. 1993 Sep;11(9):1770-9. doi: 10.1200/JCO.1993.11.9.1770. J Clin Oncol. 1993. PMID: 8355044
302 results